Nrgene Technologies Ltd (NRGN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nrgene Technologies Ltd (NRGN) has a cash flow conversion efficiency ratio of 0.392x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA1.73 Million ≈ $4.65K USD) by net assets (ILA4.42 Million ≈ $11.85K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Nrgene Technologies Ltd balance sheet quality to measure how much of total assets are equity-financed.
Nrgene Technologies Ltd - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Nrgene Technologies Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check NRGN cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Nrgene Technologies Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nrgene Technologies Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Golden Deeps Ltd
AU:GED
|
-0.030x |
|
JLEN Environmental Assets Group Ltd
LSE:JLEN
|
-0.004x |
|
Academies Australasia Group Ltd
AU:AKG
|
-0.087x |
|
Hwa Tai Industries Bhd
KLSE:8478
|
-0.010x |
|
FD Technologies Plc
LSE:FDP
|
0.086x |
|
Tapaco Public Company Limited
BK:TAPAC
|
0.056x |
|
Alta S.A.
WAR:AAT
|
-0.003x |
|
Heart Test Laboratories Inc. Common Stock
NASDAQ:HSCS
|
-558.107x |
Annual Cash Flow Conversion Efficiency for Nrgene Technologies Ltd (2018–2025)
The table below shows the annual cash flow conversion efficiency of Nrgene Technologies Ltd from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Nrgene Technologies Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ILA4.42 Million ≈ $11.85K |
ILA855.00K ≈ $2.29K |
0.193x | +121.75% |
| 2024-12-31 | ILA4.01 Million ≈ $10.74K |
ILA-3.56 Million ≈ $-9.55K |
-0.890x | -64.23% |
| 2023-12-31 | ILA7.21 Million ≈ $19.34K |
ILA-3.91 Million ≈ $-10.48K |
-0.542x | -8.55% |
| 2022-12-31 | ILA12.26 Million ≈ $32.87K |
ILA-6.12 Million ≈ $-16.40K |
-0.499x | -58.50% |
| 2021-12-31 | ILA17.68 Million ≈ $47.40K |
ILA-5.57 Million ≈ $-14.92K |
-0.315x | -222.29% |
| 2020-12-31 | ILA-5.53 Million ≈ $-14.82K |
ILA-1.42 Million ≈ $-3.82K |
0.257x | -73.19% |
| 2019-12-31 | ILA-3.73 Million ≈ $-9.99K |
ILA-3.58 Million ≈ $-9.59K |
0.960x | +51.88% |
| 2018-12-31 | ILA-1.33 Million ≈ $-3.56K |
ILA-839.00K ≈ $-2.25K |
0.632x | -- |
About Nrgene Technologies Ltd
NRGene Technologies Ltd operates as a research and development company focusing on intellectual property-intensive technological products in the field of AgTech in North America, Europe, the Middle East, Africa, Asia Pacific, and internationally. It develops and commercializes plant varieties, traits, and animals based on artificial intelligence (AI) technology and software tools for analyzing ge… Read more